TP53 mutations have been associated with a poor prognosis in HCC and hypoxia‐induced HCC stemness [37, 38], consistent with our findings that the low m7Gscore subgroup with a high TP53 mutation rate had an inferior prognosis compared to the high m7Gscore subgroup. Here, TP53 is linked to hepatocellular carcinoma.